https://www.endotools.be/2022/01/18/press-release-fda-clearance-2/2022-05-24T16:11:57+02:00https://www.endotools.be/2019/10/01/meet-us-at-uegw-2019-2/2022-05-24T16:13:32+02:00https://www.endotools.be/2020/03/13/covid-19-update-2/2022-05-24T16:12:57+02:00https://www.endotools.be/2021/01/19/press-release-endo-tools-therapeutics-secures-e8-million-9-5m-in-series-d-funding-led-by-white-fund-2/2022-05-24T16:12:34+02:00https://www.endotools.be/2022/06/01/meet-us-at-37th-geew-in-brussels-2/2022-06-08T16:29:12+02:00https://www.endotools.be/2022/06/14/endo-tools-therapeutics-receives-positive-opinion-from-french-high-authority-on-health-on-forfait-innovation-scheme-to-treat-patients-with-diabetes%ef%bf%bc/2022-08-22T18:11:11+02:00https://www.endotools.be/2022/08/22/__trashed/2022-08-22T18:28:28+02:00https://www.endotools.be/2022/09/13/meet-us-at-ueg-2022-vienna/2022-09-13T16:02:02+02:00https://www.endotools.be/2022/10/18/videodigest-2022/2022-10-18T17:02:44+02:00https://www.endotools.be/2022/10/21/ett-forums-du-cregg-2022/2022-11-21T21:38:05+01:00https://www.endotools.be/2022/11/21/1ere-journee-sfed-de-lendoscopie-bariatrique-et-metabolique/2022-11-21T21:52:55+01:00https://www.endotools.be/2023/09/15/ett-ueg-week-2023-copenhagen/2023-09-15T17:25:46+02:00https://www.endotools.be/2023/11/17/ett-first-patient-estime/2023-11-17T19:19:23+01:00https://www.endotools.be/2024/05/06/european-mdr-certification-obtained-for-endomina-and-tapes/2024-05-07T15:36:33+02:00https://www.endotools.be/2024/07/30/estime-trial-first-patient-successfully-treated-with-endomina/2024-07-30T16:12:01+02:00https://www.endotools.be/2025/03/20/meet-us-at-esge-days-2025-in-barcelona/2025-03-20T12:19:53+01:00https://www.endotools.be/2025/06/30/endo-tools-therapeutics-and-fujifilm-middle-east-fze-partner-to-extend-access-to-innovative-treatments-for-obesity/2025-10-22T14:12:22+02:00https://www.endotools.be/2025/09/03/meet-us-at-the-world-congress-of-the-international-bariatric-club-2025-in-oxford/2025-09-03T11:36:21+02:00https://www.endotools.be/2026/03/17/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system/2026-03-16T10:50:04+01:00https://www.endotools.be/2026/04/29/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system-2/2026-04-30T09:24:49+02:00https://www.endotools.be/2026/05/04/esge-days-2026-find-us-at-booth-37/2026-05-04T16:23:20+02:00https://www.endotools.be/2026/07/16/endo-tools-therapeutics-secures-23-million-in-series-c-financing-to-advance-the-endomina-technology-and-commercialization-of-new-endomina-ezfuse-system/2026-07-16T15:47:58+02:00https://www.endotools.be/2026/07/22/leadership-transition-positions-ett-for-its-next-phase-of-commercial-growth-and-physician-adoption/2026-07-22T15:10:43+02:00